UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR
SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 0-13873
DIMENSIONAL MEDICINE, INC.
(Exact name of registrant as specified in its charter)
10901 Bren Road East, Minnetonka, Minnesota 55343
(Address, including zip code, and telephone number, including
area code, of registrant's principal executive offices)
Common Stock $.15 Par Value
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to
file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate, the appropriate
rule provision(s) relied upon to terminate or suspend the duty
to file reports:
Rule 12g-4(a)(1)(i) X Rule 12h-3(b)(1)(i) X
Rule 12g-4(a)(1)(ii) Rule 12h-3(b)(1)(ii)
Rule 12g-4(a)(2)(ii) Rule 12h-3(b)(2)(i)
Rule 12g-4(a)(2)(ii) Rule 12h-3(b)(2)(ii)
Rule 15d-6 X
Appropriate number of holders of record as of the certification
or notice date: 574.
Pursuant to the requirements of the Securities Exchange Act of
1934 (Name of registrant as specified in charter) has caused
this certification/notice to be signed on its behalf by the
undersigned duly authorized person.
Date: May 9, 1996 By: /S/MITCHEL J. LASKEY
Mitchel J. Laskey,
President of DMI ACQUISITION CORP.,
successor to registrant
Instruction: This form is required by Rule 12g-4, 12h-3 and
15d-6 of the General Rules and Regulations under the Securities
Exchange Act of 1934. The registrant shall file with the
Commission three (3) copies of Form 15, one of which shall be
manually signed. It may be signed by an officer of the
registrant, by counsel or by any other duly authorized person.
The name and title of the person signing the form shall be typed
or printed under the signature.
